(Press-News.org) One of the human body's first responses to a viral infection is to make and release signaling proteins called interferons, which amplify the immune system response to viruses. Over time, many viruses have evolved to undermine interferon's immune-boosting signal, and a paper published today in the journal Cell Host & Microbe describes a mechanism unique to the Ebola virus that defeats attempts by interferon to block viral reproduction in infected cells.
The newly published study explains for the first time how the production by the virus of a protein called Ebola Viral Protein 24 (eVP24) stops the interferon-based signals from ramping up immune defenses. With the body's first response disabled, the virus is free to mass produce itself and trigger the too-large immune response that damages organs and often becomes deadly as part of Ebola virus disease (EVD).
The study was led by scientists from Washington University School of Medicine in St. Louis in collaboration with researchers from the Icahn School of Medicine at Mount Sinai and the University of Texas Southwestern Medical Center.
"Our study is the first to show how Ebola viral protein 24 defeats the signal sent by interferons, the key signaling molecules in the body's early response to Ebola virus infection," said Christopher F. Basler, PhD, Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, and an author of the newly published paper. "These newfound details of Ebola biology are already serving as the foundation of a new drug development effort, albeit in its earliest stages," said Dr. Basler, also a researcher within the Mount Sinai Global Health and Emerging Pathogens Institute.
"We've known for a long time that infection with Ebola virus obstructs an important arm in our immune system that is activated by molecules called interferons," said senior author Gaya Amarasinghe, PhD, Assistant Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis. "By determining the structure of an eVP24 in complex with a cellular transporter, we learned how Ebola does this."
Ebola Defeats Immune Defenses Early in Infection
The study spotlights the part of the body's defense system that fights infection called innate immunity, the mix of proteins and cells that most quickly recognizes an invasion by a virus. This part of immunity keeps a virus from quickly reproducing inside cells.
To trigger an effective, early response to viral infection, interferons must pass on their signal to other cells. This occurs through other messengers inside cells as part of interferon signaling pathways, with the last of these messengers turning on genes inside the nuclei of cells to drive the immune response.
The current study determined the structure of eVP24 when bound to its cellular targets, transport proteins called karyopherins. The study used these structures to show how, in place of interferon's natural downstream signal carrier phosphorylated STAT1, eVP24 docks into the karyopherins meant to escort STAT1 into cell nuclei where it turns on interferon-targeted genes. By elegantly interfering at this stage, eVP24 cripples innate immunity to cause EVD.
In 2006, Dr. Basler and colleagues found that the Ebola virus suppresses the human immune response through eVP24, but not how. Through of combination of molecular biology techniques, cell studies and tests that reveal protein structures, the current team led by Dr. Amarasighe defined the molecular basis for how eVP24 achieves this suppression.
Understanding exactly how the Ebola virus targets the interferon pathway could help guide drug development moving forward. Dr. Basler describes how it may be possible to find an antibody or molecule that interferes with eVP24, or that works around its competition with STAT1, such that treatment of patients with extra interferon, long used against the hepatitis C virus for instance, might become useful against the Ebola virus.
"We feel the urgency of the present situation, but still must do the careful research to ensure that any early drug candidates against the Ebola virus are proven to be safe, effective and ready for use in future outbreaks," said Dr. Basler, who is also principal Investigator of an NIH-funded Center of Excellence for Translational Research (CETR) focused on developing drugs to treat Ebola virus infections.
INFORMATION:
Along with Drs. Amarasinghe and Basler, the study was also conducted by
Wei Xu, Joshua Alinger, Kayla Berry and Daisy Leung from the Department of Pathology and Immunology; and by Tom Brett in the Department of Internal Medicine, all within the Washington University School of Medicine in St. Louis. Anuradha Mittal in the Department of Biomedical Engineering at Washington University was also an author. Megan Edwards, Alicia Feagins, Benjamin Yen, and Jennifer Hamilton in the Department of Microbiology within the Icahn School of Medicine at Mount Sinai were also authors on the study, along with Dominika Borek in the departments of Biophysics and Biochemistry, University of Texas Southwestern Medical Center at Dallas.
The study was funded in part by grants from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community‐based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12‐minority‐owned free‐standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.
For more information, visit http://www.mountsinai.org, or find Mount Sinai on Facebook, Twitter and YouTube.
Ebola protein blocks early step in body's counterattack on virus
Findings provide framework for new drug development efforts
2014-08-13
ELSE PRESS RELEASES FROM THIS DATE:
New insights into the survival and transmission strategy of malaria parasites
2014-08-13
HP1 proteins are found in most eukaryotic organisms and are important regulators of gene silencing. In short, HP1 induces heritable condensation of chromosomal regions. As a result genes located within these regions are not expressed. Importantly, since this conformation is reversible HP1-controlled genes can become activated without requiring changes in the underlying DNA sequence.
The team led by Till Voss at the Swiss Tropical and Public Health Institute in collaboration with colleagues from the Nanyang Technological University in Singapore engineered a mutant parasite ...
From eons to seconds, proteins exploit the same forces
2014-08-13
HOUSTON – (Aug. 13, 2014) – Nature's artistic and engineering skills are evident in proteins, life's robust molecular machines. Scientists at Rice University have now employed their unique theories to show how the interplay between evolution and physics developed these skills.
A Rice team led by biophysicists Peter Wolynes and José Onuchic used computer models to show that the energy landscapes that describe how nature selects viable protein sequences over evolutionary timescales employ essentially the same forces as those that allow proteins to fold in less than a second. ...
Why aren't campus emergency alerts taken more seriously?
2014-08-13
Well-publicized tragedies on college campuses across the United States have prompted university officials to implement alert systems that broadcast real-time warnings via text message and e-mail to students, faculty, and staff. Such systems can be highly effective tools, but only if users take them seriously. New research to be presented at the Human Factors and Ergonomics Society 2014 Annual Meeting in Chicago illustrates some factors that can determine whether campus alert systems are attended to or disregarded.
In their paper, "Taking Emergency Warnings Seriously," ...
Researchers identify tests to diagnose invasive aspergillosis with 100 percent accuracy
2014-08-13
Philadelphia, PA, August 13, 2014 – The fungal infection invasive aspergillosis (IA) can be life threatening, especially in patients whose immune systems are weakened by chemotherapy or immunosuppressive drugs. Despite the critical need for early detection, IA remains difficult to diagnose. A study in The Journal of Molecular Diagnostics compared three diagnostic tests and found that the combination of nucleic acid sequence-based amplification (NASBA) and real-time quantitative PCR (qPCR) detects aspergillosis with 100% accuracy.
IA is caused by the fungus Aspergillus ...
Are patients being discharged from hospice care to save money?
2014-08-13
New Rochelle, NY, August 13, 2014—About 1 in 5 Medicare patients is discharged from hospice care alive, whether due to patients' informed choice, a change in their condition, or inappropriate actions by the hospice to save on hospitalization costs related to terminal illness. How live discharge rates differ between hospice programs and geographic regions, and when those rates should raise red flags are among the issues explored in the article "A National Study of Live Discharges from Hospice" , published in Journal of Palliative Medicine, a peer-reviewed journal from Mary ...
Tick-tock: How to quite literally speed up a woman's biological clock
2014-08-13
The metaphor of a ticking clock is often used to refer to a woman's growing urge – from puberty onwards to menopause – to conceive before her childbearing years are over. New research in Springer's journal Human Nature shows that there's more truth to this phrase than you might think. The subtle sound of a ticking clock can quite literally speed up a woman's reproductive timing. That is, the sound of a ticking clock can lead women to want to start a family at an earlier age, especially if she was raised in a lower socio-economic community. This is according to Justin Moss ...
Smoke from Russian fires over Arctic Sea
2014-08-13
Numerous wildfires have dotted the Russian landscape this past summer fire season. Although not quite as the adage says, although still true, where there's fire there's smoke. The smoke in this image has drifted from the Eastern Russian wildfires to the Arctic Sea. Other images that have been collected over the summer show both the fires that have broken out and the accompanying smoke.
The blaze of a fire is dangerous enough but smoke is an insidious by-product of fires as well. Winds carry the smoke out of the immediate area to other parts of the world not affected ...
Involuntary eye movement a foolproof indication for ADHD diagnosis
2014-08-13
Attention Deficit Hyperactivity Disorder (ADHD) is the most commonly diagnosed – and misdiagnosed – behavioral disorder in children in America, according to the Centers for Disease Control and Prevention. Unfortunately, there are currently no reliable physiological markers to diagnose ADHD. Doctors generally diagnose the disorder by recording a medical and social history of the patient and the family, discussing possible symptoms and observing the patient's behavior. But an incorrect evaluation can lead to overmedication with Ritalin (methylphenidate), which has parents ...
Fire danger extreme in British Columbia, Canada
2014-08-13
n parts of British Columbia, Canada, the Canadian Wildfire Information System's (CWIS) interactive map shows extreme wildfire danger. The area targeted on the map is the area where these wildfires are showing up on this Aqua satellite image from August 12, 2014. The priority fires this week are all within British Columbia and have affected over 142,000 hectares (almost 351,000 acres).
According to the CWIS's report for this week: "There have been 637 new fires in the past week. The difference in the area burned in the past week is difficult to gauge, as the Northwest ...
Prostate Cancer Prevention Trial identifies men mostly likely to undergo challenging study procedure
2014-08-13
Healthy men participating in the Prostate Cancer Prevention Trial who actively participate in all steps of the clinical trial are most likely to undergo a biopsy, according to a study published in Cancer Epidemiology, Biomarkers and Prevention – a journal of the American Association for Cancer Research.
The Prostate Cancer Prevention Trial was a randomized, double-blind, placebo-controlled trial which tested the efficacy of finasteride, a drug used for prostate cancer prevention. This study was conducted by SWOG – a cancer research cooperative group that designs and ...
LAST 30 PRESS RELEASES:
Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid
Low LDL cholesterol levels linked to reduced risk of dementia
Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients
Almost one in ten people surveyed report having been harmed by the NHS in the last three years
Enhancing light control with complex frequency excitations
New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients
New insight into factors associated with a common disease among dogs and humans
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy
How VR technology is changing the game for Alzheimer’s disease
A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet
Balance between two competing nerve proteins deters symptoms of autism in mice
Use of antifungals in agriculture may increase resistance in an infectious yeast
Awareness grows of cancer risk from alcohol consumption, survey finds
The experts that can outsmart optical illusions
Pregnancy may reduce long COVID risk
Scientists uncover novel immune mechanism in wheat tandem kinase
Three University of Virginia Engineering faculty elected as AAAS Fellows
Unintentional drug overdoses take a toll across the U.S. unequally, study finds
A step toward plant-based gelatin
ECMWF unveils groundbreaking ML tool for enhanced fire prediction
The food and fuel that farms itself
Patient- and Community-Level Characteristics Associated With RSV Vaccination
[Press-News.org] Ebola protein blocks early step in body's counterattack on virusFindings provide framework for new drug development efforts